Scopia Surgical raises C$2.65M to bring AI navigation into robotic surgery
What's the deal? Montreal-based Scopia SurgicalDealroom has a profile for this one. Try Dealroom → has closed an oversubscribed C$2.65 million (roughly $1.9 million) pre-seed round to build AI-powered surgical navigation for minimally invasive and robotic procedures. The financing was co-led by Linearis VenturesDealroom has a profile for this one. Try Dealroom → and Anges Québec.
Who else backed it? Participants included Fonds Impulsion — a Quebec government initiative managed by Investissement QuébecDealroom has a profile for this one. Try Dealroom → — plus HaloHealthDealroom has a profile for this one. Try Dealroom →, Richard Rubin, Suresh Madan, and other investors.
What's the endgame? Scopia is building a software platform that fuses real-time spatial intelligence with patient-specific digital twins, aiming to let existing robotic systems operate with greater precision. "Our goal is to bring the full richness of preoperative imaging into the operating room, in real time on the systems hospitals already own to reduce complications and optimize surgical outcomes," said chief executive officer and co-founder Gabriel Rivest.
What's the money for? The company plans to grow its engineering and clinical teams, accelerate product development, and run the first clinical validation of its navigation system across several hospitals in Canada and the United States. It is also preparing for regulatory and commercialisation milestones.
Why the interest? Backers pointed to the platform's compatibility with current operating room equipment. "Scopia Surgical captured the attention of the Angels through its potential to optimize surgeons' practice with an innovative solution compatible with current operating room equipment," said Hélène Moore, Anges Québec representative.
Investor confidence: LinearisDealroom has a profile for this one. Try Dealroom → framed the raise as a bet on physical AI in a fast-growing market. "We believe Scopia could become a category-defining company," said Manon Boisclair, managing partner at Linearis Ventures.
The signal: At roughly $1.9 million, the round lands in the upper tier of pre-seed deals — around the 76th percentile by size — signalling appetite for applying AI to robotic surgery rather than building new hardware. Scopia's pitch is to upgrade the systems hospitals already own, a capital-light path into one of medtech's fastest-moving segments.
Read more: morningstar.com
Image credit: Scopia Surgical
